Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Cocrystal Pharma

COCP

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Cocrystal Pharma (COCP)

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral d...

Open: --
High: --
Low: --
Prev. Close: --
Volume: --
Turnover: --
Avg Price: --
Bid/Ask Ratio: --
Amplitude: --
52wk High: --
Volume Ratio: --
Turnover Ratio: --

52wk Low: --
Float Mkt Cap: --
Market Cap: --
P/E^TTM: --
P/E^Dynamic: --
P/E^Static: --
EPS^TTM: --
EPS^Dynamic: --
EPS^Static: --
BVPS: --
P/B: --
Circulating Supply: --
Dividend Yield^TTM: --
Dividend^TTM: --
Shares: --
Min lot size: --
Currency: --

Cocrystal Pharma Analyst Rating

Forecast & Rating

Aug 20, 2026

Price forecast

$9.00625.81%

Forecast & RatingStrong buy

1analysts

Strong buy100.00%
Buy0.00%
Hold0.00%
Sell0.00%
Strong sell0.00%

Strong buy: 1
Buy: 0
Hold: 0
Sell: 0
Strong sell: 0

News

prnewswire · Sep 9 at 01:05 AM
21:01 ETKaneka Intends to Appeal Invalidity Decision in Lawsuit Against CoCrystal
StockTitan · Aug 17 at 07:17 AM
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors | COCP Stock News
PUBT · Aug 13 at 11:31 AM
Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 million